BISARO PAUL
Insider CIK 1237253 · IPXL President and CEO, Director · ZMH Director · ZTS Director · MNKPF Director · ACT Exec Chairman, Director · AMRX Executive Chairman, Director · TXMD Director · WPI President & CEO, Director · MYGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NONE Keenova Therapeutics plc | A Award deriv | 2026-07-15 | 2026-07-17 | 4,406 | — | $0 | 46,749 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2026-06-04 | 2026-06-05 | 59,701 | — | $0 | 157,142 | SEC↗ |
| NONE Keenova Therapeutics plc | M Exercise deriv | 2026-06-02 | 2026-06-04 | 2,685 | — | $0 | 42,343 | SEC↗ |
| NONE Keenova Therapeutics plc | D To issuer deriv | 2026-06-02 | 2026-06-04 | 2,197 | — | $0 | 45,028 | SEC↗ |
| NONE Keenova Therapeutics plc | M Exercise | 2026-06-02 | 2026-06-04 | 2,685 | — | $0 | 6,863 | SEC↗ |
| NONE Keenova Therapeutics plc | F Tax w/h | 2026-06-02 | 2026-06-04 | 619 | — | $0 | 6,244 | SEC↗ |
| MYGN MYRIAD GENETICS INC | P Buy | 2026-05-14 | 2026-05-14 | 7,500 | $3.69 | $27.7K | 97,441 | SEC↗ |
| ZTS Zoetis Inc. | P Buy | 2026-05-13 | 2026-05-13 | 2,000 | $75.88 | $151.8K | 27,862 | SEC↗ |
| NONE Keenova Therapeutics plc | A Award deriv | 2026-02-23 | 2026-02-25 | 3,984 | — | $0 | 47,225 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise deriv | 2026-02-19 | 2026-02-23 | 1,619 | — | $0 | 0 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise | 2026-02-19 | 2026-02-23 | 1,619 | — | $0 | 25,862 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2026-02-18 | 2026-02-19 | 1,936 | — | $0 | 1,936 | SEC↗ |
| NONE Keenova Therapeutics plc | M Exercise deriv | 2026-01-01 | 2026-01-05 | 3,014 | — | $0 | 43,241 | SEC↗ |
| NONE Keenova Therapeutics plc | D To issuer deriv | 2026-01-01 | 2026-01-05 | 2,466 | — | $0 | 46,255 | SEC↗ |
| NONE Keenova Therapeutics plc | F Tax w/h | 2026-01-01 | 2026-01-05 | 854 | — | $0 | 4,178 | SEC↗ |
| NONE Keenova Therapeutics plc | M Exercise | 2026-01-01 | 2026-01-05 | 3,014 | — | $0 | 5,032 | SEC↗ |
| NONE Mallinckrodt plc | A Award deriv | 2025-08-14 | 2025-08-18 | 4,062 | — | $0 | 40,538 | SEC↗ |
| NONE Mallinckrodt plc | A Award deriv | 2025-07-31 | 2025-08-04 | 27,357 | — | $0 | 36,476 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2025-06-05 | 2025-06-06 | 49,796 | — | $0 | 89,941 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2025-02-19 | 2025-02-20 | 1,596 | — | $0 | 1,596 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise deriv | 2025-02-08 | 2025-02-11 | 1,225 | — | $0 | 0 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise | 2025-02-08 | 2025-02-11 | 1,225 | — | $0 | 24,243 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise deriv | 2025-02-06 | 2025-02-10 | 1,236 | — | $0 | 0 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise | 2025-02-06 | 2025-02-10 | 1,236 | — | $0 | 23,018 | SEC↗ |
| NONE Mallinckrodt plc | D To issuer deriv | 2025-01-01 | 2025-01-02 | 2,052 | — | $0 | 11,626 | SEC↗ |
| NONE Mallinckrodt plc | M Exercise deriv | 2025-01-01 | 2025-01-02 | 2,507 | — | $0 | 9,119 | SEC↗ |
| NONE Mallinckrodt plc | F Tax w/h | 2025-01-01 | 2025-01-02 | 489 | — | $0 | 2,018 | SEC↗ |
| NONE Mallinckrodt plc | M Exercise | 2025-01-01 | 2025-01-02 | 2,507 | — | $0 | 2,507 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2024-06-06 | 2024-06-07 | 15,695 | — | $0 | 40,145 | SEC↗ |
| NONE Mallinckrodt plc | A Award deriv | 2024-02-19 | 2024-02-20 | 13,678 | — | $0 | 13,678 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise deriv | 2024-02-10 | 2024-02-13 | 1,463 | — | $0 | 1,212 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise | 2024-02-10 | 2024-02-13 | 1,463 | — | $0 | 21,782 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise deriv | 2024-02-08 | 2024-02-12 | 1,493 | — | $0 | 0 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise | 2024-02-08 | 2024-02-12 | 1,493 | — | $0 | 20,319 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2024-02-06 | 2024-02-08 | 1,223 | — | $0 | 1,223 | SEC↗ |
| MNKTQ Mallinckrodt plc | D To issuer | 2023-11-14 | 2023-11-16 | 32,048 | — | $0 | 0 | SEC↗ |
| MNK Mallinckrodt plc | D To issuer | 2023-06-16 | 2023-06-29 | 39,083 | — | $0 | 32,048 | SEC↗ |
| MNK Mallinckrodt plc | F Tax w/h | 2023-06-16 | 2023-06-29 | 3,689 | $1.28 | $4.7K | 71,131 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2023-06-01 | 2023-06-02 | 7,575 | — | $0 | 24,450 | SEC↗ |
| MNK Mallinckrodt plc | P Buy | 2023-03-14 | 2023-03-16 | 5,000 | $8.47 | $42.4K | 74,820 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise deriv | 2023-02-11 | 2023-02-14 | 1,627 | — | $0 | 2,652 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise | 2023-02-11 | 2023-02-14 | 1,626 | — | $0 | 18,826 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2023-02-08 | 2023-02-10 | 1,480 | — | $0 | 1,480 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2023-01-03 | 2023-01-05 | 39,083 | — | $0 | 69,820 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2022-10-31 | 2022-11-01 | 16,875 | — | $0 | 16,875 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2022-09-29 | 2022-10-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2022-08-18 | 2022-08-22 | 1,984 | — | $0 | 0 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2022-08-18 | 2022-08-22 | 1,984 | — | $0 | 5,922 | SEC↗ |
| MNKPF Mallinckrodt plc | D To issuer deriv | 2022-08-16 | 2022-09-14 | 44,354 | — | $0 | 30,737 | SEC↗ |
| MNKPF Mallinckrodt plc | A Award deriv | 2022-07-01 | 2022-07-06 | 75,091 | — | $0 | 75,091 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise deriv | 2022-02-12 | 2022-02-15 | 2,673 | — | $0 | 4,245 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise | 2022-02-12 | 2022-02-15 | 2,673 | — | $0 | 17,200 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2022-02-08 | 2022-02-10 | 1,192 | — | $0 | 6,918 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | P Buy | 2021-08-16 | 2021-08-18 | 50,000 | $0.79 | $39.5K | 196,864 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2021-08-10 | 2021-08-12 | 96,864 | — | $0 | 0 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2021-08-10 | 2021-08-12 | 96,864 | — | $0 | 146,864 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2021-07-01 | 2021-07-02 | 99,174 | — | $0 | 99,174 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise deriv | 2021-02-13 | 2021-02-17 | 2,779 | — | $0 | 5,695 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise | 2021-02-13 | 2021-02-17 | 2,779 | — | $0 | 14,527 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 1,431 | — | $0 | 8,474 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 96,864 | — | $0 | 96,864 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | P Buy | 2020-06-04 | 2020-06-08 | 50,000 | $1.14 | $57.0K | 50,000 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise deriv | 2020-02-14 | 2020-02-19 | 3,705 | — | $0 | 7,003 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise | 2020-02-14 | 2020-02-19 | 3,704 | — | $0 | 11,748 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2020-02-11 | 2020-02-13 | 1,596 | — | $0 | 10,708 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2019-05-07 | 2019-05-09 | 24,983 | — | $0 | 74,950 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2019-05-07 | 2019-05-09 | 12,529 | $13.44 | $168.4K | 29,454 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2019-05-07 | 2019-05-09 | 24,983 | — | $0 | 41,983 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | P Buy | 2019-03-12 | 2019-03-12 | 17,000 | $11.97 | $203.5K | 17,000 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-03-01 | 2019-03-05 | 175,968 | — | $0 | 175,968 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-03-01 | 2019-03-05 | 86,420 | — | $0 | 86,420 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise deriv | 2019-02-19 | 2019-02-21 | 4,150 | — | $0 | 9,058 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise | 2019-02-19 | 2019-02-21 | 4,150 | — | $0 | 8,044 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2019-02-12 | 2019-02-14 | 2,628 | — | $0 | 13,209 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-07 | 2018-05-08 | 99,933 | — | $0 | 99,933 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-07 | 2018-05-08 | 408,719 | — | $0 | 408,719 | SEC↗ |
| IPXL Impax Laboratories, LLC | D To issuer deriv | 2018-05-04 | 2018-05-08 | 850,000 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2018-05-04 | 2018-05-08 | 850,000 | — | $0 | 850,000 | SEC↗ |
| AGN Allergan plc | A Award | 2018-05-02 | 2018-05-04 | 1,985 | $151.07 | $299.9K | 263,729 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise deriv | 2018-05-01 | 2018-05-03 | 3,895 | — | $0 | 10,530 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2018-05-01 | 2018-05-03 | 588 | $152.94 | $89.9K | 261,744 | SEC↗ |
| ZTS Zoetis Inc. | M Exercise | 2018-05-01 | 2018-05-03 | 3,894 | — | $0 | 3,894 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2018-03-05 | 2018-03-06 | 2,921 | $148.73 | $434.4K | 262,332 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2018-02-13 | 2018-02-15 | 2,730 | $73.24 | $199.9K | 14,403 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-12-29 | 2018-01-02 | 6,521 | $163.58 | $1.07M | 265,253 | SEC↗ |
| AGN Allergan plc | M Exercise deriv | 2017-10-27 | 2017-10-30 | 37,727 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | M Exercise | 2017-10-26 | 2017-10-30 | 37,727 | — | $0 | 271,774 | SEC↗ |
| AGN Allergan plc | A Award | 2017-05-04 | 2017-05-05 | 1,223 | $245.25 | $299.9K | 234,047 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-05-03 | 2017-05-05 | 214 | $243.76 | $52.2K | 232,824 | SEC↗ |
| ZBH ZIMMER BIOMET HOLDINGS, IN | A Award deriv | 2017-03-31 | 2017-04-04 | 98 | — | $0 | 3,095 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award deriv | 2017-03-27 | 2017-03-29 | 850,000 | — | $0 | 850,000 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-03-05 | 2017-03-07 | 2,862 | $245.63 | $703.0K | 233,038 | SEC↗ |
| AGN Allergan plc | S Sale | 2017-03-02 | 2017-03-06 | 2,371 | $248.40 | $589.0K | 235,900 | SEC↗ |
| AGN Allergan plc | S Sale | 2017-03-02 | 2017-03-06 | 8,267 | $246.64 | $2.04M | 265,959 | SEC↗ |
| AGN Allergan plc | S Sale | 2017-03-02 | 2017-03-06 | 27,688 | $247.63 | $6.86M | 238,271 | SEC↗ |
| AGN Allergan plc | S Sale | 2017-03-02 | 2017-03-06 | 31,674 | $245.73 | $7.78M | 274,226 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2017-02-14 | 2017-02-16 | 3,635 | $55.02 | $200.0K | 11,594 | SEC↗ |
| AGN Allergan plc | A Award | 2017-02-02 | 2017-02-06 | 444 | $229.52 | $101.9K | 305,900 | SEC↗ |
| AGN Allergan plc | C Conversion deriv | 2017-02-01 | 2017-02-03 | 7,105 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | C Conversion deriv | 2017-02-01 | 2017-02-06 | 7,105 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | A Award | 2017-02-01 | 2017-02-03 | 7,105 | $229.32 | $1.63M | 188,867 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-02-01 | 2017-02-03 | 3,411 | $229.32 | $782.2K | 185,456 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-02-01 | 2017-02-06 | 3,411 | $229.32 | $782.2K | 305,456 | SEC↗ |
| AGN Allergan plc | A Award | 2017-02-01 | 2017-02-06 | 7,105 | $229.32 | $1.63M | 308,867 | SEC↗ |
| ZBH ZIMMER BIOMET HOLDINGS, IN | A Award deriv | 2016-12-31 | 2017-01-04 | 115 | — | $0 | 2,992 | SEC↗ |
| ZBH ZIMMER BIOMET HOLDINGS, IN | A Award deriv | 2016-09-30 | 2016-10-04 | 92 | — | $0 | 2,871 | SEC↗ |
| ZBH ZIMMER BIOMET HOLDINGS, IN | A Award deriv | 2016-06-30 | 2016-07-01 | 99 | — | $0 | 2,775 | SEC↗ |
| ZBH ZIMMER BIOMET HOLDINGS, IN | A Award deriv | 2016-05-03 | 2016-05-05 | 500 | — | $0 | 2,675 | SEC↗ |
| ZBH ZIMMER BIOMET HOLDINGS, IN | A Award deriv | 2016-05-03 | 2016-05-05 | 1,128 | — | $0 | 3,515 | SEC↗ |
| ZBH ZIMMER BIOMET HOLDINGS, IN | A Award deriv | 2016-03-31 | 2016-04-04 | 111 | — | $0 | 2,171 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2016-02-19 | 2016-02-22 | 4,064 | $41.83 | $170.0K | 7,896 | SEC↗ |
| ZBH ZIMMER BIOMET HOLDINGS, IN | A Award deriv | 2015-12-31 | 2016-01-05 | 116 | — | $0 | 2,055 | SEC↗ |
| ZBH ZIMMER BIOMET HOLDINGS, IN | A Award deriv | 2015-09-30 | 2015-10-02 | 126 | — | $0 | 1,935 | SEC↗ |
| AGN Allergan plc | P Buy | 2015-08-24 | 2015-08-24 | 1,000 | $297.42 | $297.4K | 421,755 | SEC↗ |
| AGN Allergan plc | G Gift | 2015-07-31 | 2015-12-30 | 120,000 | — | $0 | 120,000 | SEC↗ |
| ZBH ZIMMER BIOMET HOLDINGS, IN | A Award deriv | 2015-06-30 | 2015-07-01 | 108 | — | $0 | 1,805 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | A Award deriv | 2015-05-05 | 2015-05-07 | 1,180 | — | $0 | 2,387 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | A Award deriv | 2015-05-05 | 2015-05-07 | 500 | — | $0 | 1,697 | SEC↗ |
| ZTS Zoetis Inc. | A Award deriv | 2015-05-01 | 2015-05-01 | 3,811 | $44.60 | $170.0K | 3,811 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | A Award deriv | 2015-03-31 | 2015-04-02 | 101 | — | $0 | 1,195 | SEC↗ |
| ACT Actavis plc | A Award | 2015-03-05 | 2015-03-09 | 13,702 | — | $0 | 422,531 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-03-05 | 2015-03-09 | 1,776 | $295.70 | $525.2K | 420,755 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-03-05 | 2015-03-09 | 1,316 | $295.70 | $389.1K | 408,829 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | A Award deriv | 2014-12-31 | 2015-01-05 | 104 | — | $0 | 1,092 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | A Award deriv | 2014-09-30 | 2014-10-02 | 117 | — | $0 | 987 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 85,743 | — | $0 | 85,743 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 78,029 | — | $0 | 78,029 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | A Award deriv | 2014-06-30 | 2014-07-02 | 114 | — | $0 | 868 | SEC↗ |
| ACT Actavis plc | A Award | 2014-05-09 | 2014-05-13 | 10,150 | $197.05 | $2.00M | 410,145 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | A Award deriv | 2014-05-06 | 2014-05-08 | 500 | — | $0 | 754 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | A Award deriv | 2014-05-06 | 2014-05-08 | 1,207 | — | $0 | 1,207 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | A Award deriv | 2014-03-31 | 2014-04-02 | 126 | — | $0 | 253 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | A Award deriv | 2013-12-31 | 2014-01-02 | 127 | — | $0 | 127 | SEC↗ |
| ACT Actavis plc | S Sale | 2013-11-11 | 2013-11-13 | 17,643 | $159.07 | $2.81M | 399,995 | SEC↗ |
| ACT Actavis plc | S Sale | 2013-11-11 | 2013-11-13 | 23,278 | $158.48 | $3.69M | 417,638 | SEC↗ |
| ACT Actavis, Inc. | D To issuer | 2013-10-01 | 2013-10-02 | 440,916 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | A Award | 2013-10-01 | 2013-10-03 | 440,916 | — | $0 | 440,916 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-09-30 | 2013-10-02 | 162,076 | $144.00 | $23.34M | 440,916 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-09-30 | 2013-10-02 | 140,760 | — | $0 | 602,992 | SEC↗ |
| ACT Actavis, Inc. | G Gift | 2013-09-13 | 2013-09-17 | 7,000 | — | $0 | 462,232 | SEC↗ |
| ACT Actavis, Inc. | S Sale | 2013-08-20 | 2013-08-22 | 50,000 | $135.30 | $6.77M | 469,232 | SEC↗ |
| ACT Actavis, Inc. | M Exercise deriv | 2013-08-07 | 2013-08-09 | 527,200 | — | $0 | 0 | SEC↗ |
| ACT Actavis, Inc. | M Exercise | 2013-08-07 | 2013-08-09 | 527,200 | $30.66 | $16.16M | 843,293 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-08-07 | 2013-08-09 | 324,061 | $135.43 | $43.89M | 519,232 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-03-06 | 2013-03-08 | 29,479 | — | $0 | 293,067 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-03-06 | 2013-03-08 | 23,026 | — | $0 | 316,093 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-03-05 | 2013-03-07 | 19,068 | $86.46 | $1.65M | 263,588 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-03-02 | 2013-03-05 | 24,683 | $85.54 | $2.11M | 282,656 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | F Tax w/h | 2012-03-14 | 2012-03-16 | 6,521 | $59.21 | $386.1K | 307,339 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-03-08 | 2012-03-12 | 28,510 | — | $0 | 313,860 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-03-08 | 2012-03-12 | 33,423 | — | $0 | 285,350 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | F Tax w/h | 2012-02-24 | 2012-02-28 | 16,759 | $58.17 | $974.9K | 251,927 | SEC↗ |